APA

Mita A. C., Takimoto C. H., Mita M., Tolcher A., Sankhala K., Sarantopoulos J., Valdivieso M., Wood L., Rasmussen E., Sun Y., Zhong Z. D., Bass M. B., Le N. & LoRusso P. (20100812). Phase 1 study of AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, in combination with chemotherapy in adults with advanced solid tumors. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Mita Alain C, Takimoto Chris H, Mita Monica, Tolcher Anthony, Sankhala Kamalesh, Sarantopoulos John, Valdivieso Manuel, Wood Leslie, Rasmussen Erik, Sun Yu-Nien, Zhong Z Don, Bass Michael B, Le NgocDiep and LoRusso Patricia. 20100812. Phase 1 study of AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, in combination with chemotherapy in adults with advanced solid tumors. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Mita A. C., Takimoto C. H., Mita M., Tolcher A., Sankhala K., Sarantopoulos J., Valdivieso M., Wood L., Rasmussen E., Sun Y., Zhong Z. D., Bass M. B., Le N. and LoRusso P. (20100812). Phase 1 study of AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, in combination with chemotherapy in adults with advanced solid tumors. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Mita Alain C, Takimoto Chris H, Mita Monica, Tolcher Anthony, Sankhala Kamalesh, Sarantopoulos John, Valdivieso Manuel, Wood Leslie, Rasmussen Erik, Sun Yu-Nien, Zhong Z Don, Bass Michael B, Le NgocDiep and LoRusso Patricia. Phase 1 study of AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, in combination with chemotherapy in adults with advanced solid tumors. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20100812.